Asia-Pacific Animal Health Market Worth USD 20.25 Billion by 2021

PUNE, India, October 21, 2016 /PRNewswire/ --

According to a new market research report "Asia-Pacific Animal Health Market by Product [Parasiticides (Endoparasiticides, Ectoparasiticides), Antimicrobial & Antibiotic, Vaccines, Feed Additive (Vitamin, Amino Acids, Antioxidant), Growth Promoter], Animal [Livestock, Companion] - Forecast to 2021" The APAC animal health market has witnessed significant growth during the last decade and is expected to grow at a CAGR of 5.7% during the forecast period to reach USD 20.25 Billion by 2021.

     (Logo: http://photos.prnewswire.com/prnh/20160303/792302 )

Browse 116 market data Tables and 35 Figures spread through 199 Pages and in-depth TOC on "Asia-Pacific Animal Health Market" 

http://www.marketsandmarkets.com/Market-Reports/asia-pacific-animal-health-market-130378405.html

Early buyers will receive 10% customization on this report.

The report analyzes and studies the major market drivers, restraints, challenges, and opportunities in China, Japan, India, and the Rest of Asia-Pacific

Growth in this market can majorly be attributed to factors such as rapidly increasing livestock population, increasing demand for animal-derived food products, growing awareness about animal health, and rising frequency of animal disease outbreaks. However, the shift towards vegetarian diets, rising cost of vaccine storage, and restrictions on the use of parasiticides in food-producing animals are expected to restrain the growth of the APAC animal health market. Growth in companion animal ownership and rising adoption of pet health insurance in APAC offer significant growth opportunities for players operating in the APAC animal health market.

The APAC animal health market is segmented based on product, type of animal, and country. In 2015, the growth promoters segment accounted for the largest share of the APAC animal health market, while the vaccines segment is expected to witness the highest growth during the forecast period. Growth in this segment can be attributed to the higher utilization of vaccines as a preventive measure for various animal diseases by veterinarians, livestock producers, and pet owners. The food-producing animals segment accounted for the largest share of the APAC animal health market, by type of animal.

Ask for PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=130378405

China is the largest regional segment for the APAC Animal Health Market and is expected to witness the highest growth rate during the forecast period. The large share of this regional segment is driven by the increasing livestock population, rising demand for animal-derived food products in China, increasing pet ownership, and growing adoption of pet insurance. Key players operating in this market include Zoetis, Inc. (U.S.), Sanofi (France), Merck and Co., Inc. (U.S.), Eli Lilly and Company (U.S.), and Boehringer Ingelheim GmbH (Germany).

Other players include Bayer AG (Germany), Ceva Santé Animale (France), Virbac (France), Perrigo Company Plc. (U.S.), Vetoquinol S.A. (France), Cargill, Inc. (U.S.), Royal DSM N.V. (Netherlands), and Evonik Industries AG (Germany).

Browse Related Reports: 

Animal Parasiticides Market by Product (Endoparasiticides, Ectoparasiticides, Endectocides, Oral Liquids, Tablets, Injectables, Sprays, Pour-on, Spot-on, Collars, Ear Tags) by Animal (Dogs, Cats, Cattle, Pigs, Sheep and Goats, Poultry) - Global Forecast to 2020

http://www.marketsandmarkets.com/Market-Reports/animal-parasiticide-market-258895412.html

Veterinary/Animal Vaccines Market Product (Porcine, (Companion-Canine), (Livestock-Bovine), Poultry, Aquaculture), Diseases (Rabies, FMD, Swine Influenza, Strangles, Furunculous), Technology (DNA, Recombinant, Inactivated, Conjugate) - Forecast to 2021

http://www.marketsandmarkets.com/Market-Reports/animal-veterinary-vaccines-market-1233.html

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Knowledgestore.asp

Contact:
Mr. Rohan
MarketsandMarkets
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Telephone No: 1-888-600-6441
Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/pharmaceuticals

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

SOURCE MarketsandMarkets